ID   FOXC2_MOUSE             Reviewed;         494 AA.
AC   Q61850; P97948; Q63869; Q8C694;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   07-APR-2021, entry version 165.
DE   RecName: Full=Forkhead box protein C2;
DE   AltName: Full=Brain factor 3;
DE            Short=BF-3;
DE   AltName: Full=Forkhead-related protein FKHL14;
DE   AltName: Full=Mesenchyme fork head protein 1;
DE            Short=MFH-1 protein;
DE   AltName: Full=Transcription factor FKH-14;
GN   Name=Foxc2; Synonyms=Fkh14, Fkhl14, Mfh1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Embryo;
RX   PubMed=8674414;
RA   Kaestner K.H., Bleckmann S.C., Monaghan A.P., Schlondorff J., Mincheva A.,
RA   Lichter P., Schuetz G.;
RT   "Clustered arrangement of winged helix genes fkh-6 and MFH-1: possible
RT   implications for mesoderm development.";
RL   Development 122:1751-1758(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND FUNCTION.
RC   STRAIN=129, and ICR; TISSUE=Embryo;
RX   PubMed=9169153; DOI=10.1006/geno.1997.4695;
RA   Miura N., Iida K., Kakinuma H., Yang X.-L., Sugiyama T.;
RT   "Isolation of the mouse (MFH-1) and human (FKHL 14) mesenchyme fork head-1
RT   genes reveals conservation of their gene and protein structures.";
RL   Genomics 41:489-492(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Skin;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 34-494.
RX   PubMed=8325367; DOI=10.1016/0014-5793(93)81785-x;
RA   Miura N., Wanaka A., Tohyama M., Tanaka K.;
RT   "MFH-1, a new member of the fork head domain family, is expressed in
RT   developing mesenchyme.";
RL   FEBS Lett. 326:171-176(1993).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231; SER-239 AND SER-287, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Kidney, and Lung;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-278; ARG-292 AND ARG-452, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryo;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- FUNCTION: Transcriptional activator. Might be involved in the formation
CC       of special mesenchymal tissues. {ECO:0000269|PubMed:9169153}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00089}.
CC   -!- DEVELOPMENTAL STAGE: Expressed temporally in developing embryos, first
CC       in the non-notochordal mesoderm and later in areas of mesenchymal
CC       condensation in the trunk, head and limbs.
CC   -!- PTM: Phosphorylation regulates FOXC2 transcriptional activity by
CC       promoting its recruitment to chromatin. {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X92499; CAA63244.1; -; mRNA.
DR   EMBL; Y08222; CAA69399.1; -; Genomic_DNA.
DR   EMBL; X74040; CAA52192.1; -; mRNA.
DR   EMBL; AK076319; BAC36298.1; -; mRNA.
DR   EMBL; S63607; AAB27463.1; -; mRNA.
DR   CCDS; CCDS40499.1; -.
DR   PIR; S34472; S34472.
DR   RefSeq; NP_038547.2; NM_013519.2.
DR   SMR; Q61850; -.
DR   STRING; 10090.ENSMUSP00000055290; -.
DR   iPTMnet; Q61850; -.
DR   PhosphoSitePlus; Q61850; -.
DR   MaxQB; Q61850; -.
DR   PaxDb; Q61850; -.
DR   PRIDE; Q61850; -.
DR   ProteomicsDB; 271791; -.
DR   Antibodypedia; 17195; 541 antibodies.
DR   Ensembl; ENSMUST00000054691; ENSMUSP00000055290; ENSMUSG00000046714.
DR   GeneID; 14234; -.
DR   KEGG; mmu:14234; -.
DR   UCSC; uc012glx.1; mouse.
DR   CTD; 2303; -.
DR   MGI; MGI:1347481; Foxc2.
DR   eggNOG; KOG2294; Eukaryota.
DR   GeneTree; ENSGT00940000162619; -.
DR   HOGENOM; CLU_035722_3_1_1; -.
DR   InParanoid; Q61850; -.
DR   OMA; HMCVPPA; -.
DR   OrthoDB; 1270467at2759; -.
DR   PhylomeDB; Q61850; -.
DR   TreeFam; TF316127; -.
DR   BioGRID-ORCS; 14234; 3 hits in 52 CRISPR screens.
DR   PRO; PR:Q61850; -.
DR   Proteomes; UP000000589; Chromosome 8.
DR   RNAct; Q61850; protein.
DR   Bgee; ENSMUSG00000046714; Expressed in cardiac ventricle and 262 other tissues.
DR   ExpressionAtlas; Q61850; baseline and differential.
DR   Genevisible; Q61850; MM.
DR   GO; GO:0016604; C:nuclear body; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0031490; F:chromatin DNA binding; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:MGI.
DR   GO; GO:0001216; F:DNA-binding transcription activator activity; IDA:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:MGI.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IGI:MGI.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; IDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:MGI.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:MGI.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:MGI.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; IBA:GO_Central.
DR   GO; GO:0048844; P:artery morphogenesis; IMP:MGI.
DR   GO; GO:0001568; P:blood vessel development; IGI:MGI.
DR   GO; GO:0097746; P:blood vessel diameter maintenance; IGI:MGI.
DR   GO; GO:0001974; P:blood vessel remodeling; IGI:MGI.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; IGI:MGI.
DR   GO; GO:0043010; P:camera-type eye development; IMP:MGI.
DR   GO; GO:0060038; P:cardiac muscle cell proliferation; IGI:MGI.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0008283; P:cell population proliferation; IMP:MGI.
DR   GO; GO:0030199; P:collagen fibril organization; IMP:MGI.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; IMP:MGI.
DR   GO; GO:0035050; P:embryonic heart tube development; IGI:MGI.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IMP:MGI.
DR   GO; GO:0048703; P:embryonic viscerocranium morphogenesis; IMP:MGI.
DR   GO; GO:0072011; P:glomerular endothelium development; IMP:MGI.
DR   GO; GO:0072144; P:glomerular mesangial cell development; IMP:MGI.
DR   GO; GO:0072112; P:glomerular visceral epithelial cell differentiation; IMP:MGI.
DR   GO; GO:0007507; P:heart development; IMP:MGI.
DR   GO; GO:0003007; P:heart morphogenesis; IGI:MGI.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IMP:MGI.
DR   GO; GO:0001945; P:lymph vessel development; IGI:MGI.
DR   GO; GO:0001946; P:lymphangiogenesis; ISS:UniProtKB.
DR   GO; GO:0001656; P:metanephros development; IMP:MGI.
DR   GO; GO:1902257; P:negative regulation of apoptotic process involved in outflow tract morphogenesis; IGI:MGI.
DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0014032; P:neural crest cell development; IGI:MGI.
DR   GO; GO:0007219; P:Notch signaling pathway; IGI:MGI.
DR   GO; GO:0001503; P:ossification; IMP:MGI.
DR   GO; GO:0048341; P:paraxial mesoderm formation; IGI:MGI.
DR   GO; GO:0048343; P:paraxial mesodermal cell fate commitment; IMP:MGI.
DR   GO; GO:0033630; P:positive regulation of cell adhesion mediated by integrin; IDA:BHF-UCL.
DR   GO; GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; IDA:BHF-UCL.
DR   GO; GO:0010595; P:positive regulation of endothelial cell migration; IDA:BHF-UCL.
DR   GO; GO:0033625; P:positive regulation of integrin activation; IC:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0035470; P:positive regulation of vascular wound healing; IDA:BHF-UCL.
DR   GO; GO:0046620; P:regulation of organ growth; IGI:MGI.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0009725; P:response to hormone; ISS:UniProtKB.
DR   GO; GO:0001501; P:skeletal system development; IMP:MGI.
DR   GO; GO:0001756; P:somitogenesis; IGI:UniProtKB.
DR   GO; GO:0001657; P:ureteric bud development; IMP:MGI.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IGI:MGI.
DR   GO; GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IGI:MGI.
DR   CDD; cd00059; FH; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR001766; Fork_head_dom.
DR   InterPro; IPR018122; TF_fork_head_CS_1.
DR   InterPro; IPR030456; TF_fork_head_CS_2.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00250; Forkhead; 1.
DR   PRINTS; PR00053; FORKHEAD.
DR   SMART; SM00339; FH; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   PROSITE; PS00657; FORK_HEAD_1; 1.
DR   PROSITE; PS00658; FORK_HEAD_2; 1.
DR   PROSITE; PS50039; FORK_HEAD_3; 1.
PE   1: Evidence at protein level;
KW   Activator; Developmental protein; DNA-binding; Isopeptide bond;
KW   Methylation; Nucleus; Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..494
FT                   /note="Forkhead box protein C2"
FT                   /id="PRO_0000091809"
FT   DNA_BIND        70..161
FT                   /note="Fork-head"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00089"
FT   COMPBIAS        162..166
FT                   /note="Poly-Arg"
FT   COMPBIAS        386..395
FT                   /note="His-rich"
FT   COMPBIAS        396..411
FT                   /note="Pro-rich"
FT   MOD_RES         214
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99958"
FT   MOD_RES         218
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99958"
FT   MOD_RES         231
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         239
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         246
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99958"
FT   MOD_RES         250
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99958"
FT   MOD_RES         278
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         280
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99958"
FT   MOD_RES         287
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         292
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         366
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99958"
FT   MOD_RES         452
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   CROSSLNK        183
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99958"
FT   CROSSLNK        213
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99958"
FT   CONFLICT        12..13
FT                   /note="AL -> V (in Ref. 1; CAA63244)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        182
FT                   /note="L -> I (in Ref. 3; BAC36298)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        388
FT                   /note="H -> Q (in Ref. 3; BAC36298)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   494 AA;  52874 MW;  232C0D6FA64320A6 CRC64;
     MQARYSVSDP NALGVVPYLS EQNYYRAAGS YGGMASPMGV YSGHPEQYGA GMGRSYAPYH
     HQPAAPKDLV KPPYSYIALI TMAIQNAPEK KITLNGIYQF IMDRFPFYRE NKQGWQNSIR
     HNLSLNECFV KVPRDDKKPG KGSYWTLDPD SYNMFENGSF LRRRRRFKKK DVPKDKEERA
     HLKEPPSTTA KGAPTGTPVA DGPKEAEKKV VVKSEAASPA LPVITKVETL SPEGALQASP
     RSASSTPAGS PDGSLPEHHA AAPNGLPGFS VETIMTLRTS PPGGDLSPAA ARAGLVVPPL
     ALPYAAAPPA AYTQPCAQGL EAAGSAGYQC SMRAMSLYTG AERPAHVCVP PALDEALSDH
     PSGPGSPLGA LNLAAGQEGA LGASGHHHQH HGHLHPQAPP PAPQPPPAPQ PATQATSWYL
     NHGGDLSHLP GHTFATQQQT FPNVREMFNS HRLGLDNSSL GESQVSNASC QLPYRATPSL
     YRHAAPYSYD CTKY
//
